Private Equity
ChromaDex Corp. has named Steve Allen to its board of directors. A former Nestle executive, Allen is currently the non-executive vice-chairman of the LA-based investment firm 6 Pacific Group. Based in Irvine, Calif., ChromaDex, which is backed by DSM Venturing, is a natural products company.
3 min read · 03 January 2014
MELA Sciences has named Jeffrey F. O’Donnell to its board. O'Donnell is a managing director at BioStar Ventures. Also, Rose Crane, CEO of MELA, has assumed CFO duties on an interim basis following the resignation of Richard I. Steinhart, who also served as senior vice president of finance. Based in Irvington, NY, MELA Sciences is a medical device company that assists dermatologists in melanoma evaluation and diagnosis.
4 min read · 03 January 2014
GrowLife said Friday that Alan R. Hammer has joined its board. Hammer joins GrowLife via a Board seat allocated to CANX USA. In November, CANX agreed to provide up to $40 million to Growlife. Woodland Hills, Calif.-based GrowLife develops, markets and deploys products and services that serve legal cannabis growing and retail operations. Hammer, an attorney, is active in the acquisition, ownership, management and operation of investment properties, throughout New Jersey,Eastern Pennsylvania and New York State, GrowLife said.
4 min read · 03 January 2014
David Goldberg was promoted to CEO of ScoreBig.com. He succeeds ScoreBig.com co-founder and CEO Adam Kanner who is assuming the role of executive chairman. Goldberg was most recently ScoreBig.com’s chief strategy officer. Los Angeles-based ScoreBig.com is an online marketplace that aims to liquidate unsold ticket inventory. It is backed by Bain Capital Ventures, U.S. Venture Partners and the Checketts Partners Investment Fund.
3 min read · 03 January 2014
Scholar Rock said Thursday that it has named Katrine Bosley and Dr. Michael Gilman to its board of directors. Katrine Bosley is currently the entrepreneur-in-residence at The Broad Institute while Dr. Gilman is a venture partner at Atlas Venture. Based in Cambridge, Mass., Scholar Rock is a biotech company focused on the disease microenvironment.
4 min read · 02 January 2014
C2FO has named John Adams, David G. Brown, Lance T. LeMay and Jay Mandelbaum to its advisory board. Adams is a managing director at XMS Capital while Brown is a managing partner of Oak Hill Venture Partners and a vice president of Keystone. Also, LeMay works as a managing director at OpenAir Equity Partners and Mandelbaum recently served as executive vice president and operating committee member at JPMorgan Chase & Co. C2FO is the world's market for working capital.
3 min read · 30 December 2013
The DFJ founder plans a period of exploration with a focus on Draper University
3 min read · 30 December 2013
Claremont Creek Ventures, a seed and early-stage venture fund, has named Harveen Sethi as an associate. Prior to joining CCV, Sethi worked at Medtronic.
2 min read · 20 December 2013
Symphogen, a Copenhagen-based biopharmaceutical company, has named Annika Espander Jansson as a non-executive director of the board. The appointment was effective December 19, 2013. Jansson is currently the founder and CEO of Asperia. Symphogen's backers include Novo, Essex Woodlands Health Ventures and PKA.
3 min read · 20 December 2013
Atterocor said Wednesday that it has beefed up its clinical advisory board with eight additions. Among them are Dr. Wiebke Arlt and Dr. Eric Baudin. Based in Ann Arbor, Michigan, Atterocor is a company that is focused on treating adrenal cancer. Its backers include Frazier Healthcare, Osage University Partners and 5AM Ventures.
4 min read · 18 December 2013
